To gain insight into RKIP effect on NPC radioresponse, we performed in vitro and in vivo radioresponse assays with a combination of loss-of-function and gain-of-function approaches, and demonstrate that reduced RKIP enhances radioresistance in the NPC cells and xenograft tumors. Here, PEBP1 is linked to nasopharyngeal carcinoma.